MACK | Merrimack Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	15.14 - 15.17
52 Week Range	11.53 - 15.89
Beta	1.02
Implied Volatility	111.63%
IV Rank	14.81%
Day's Volume	922,504
Average Volume	182,633
Shares Outstanding	14,788,400
Market Cap	223,970,318
Sector	Healthcare
Industry	Biotechnology
IPO Date	2012-03-29

Valuation
Profitability
Growth
Health
P/E Ratio	-168.28
Forward P/E Ratio	N/A
EPS	-0.09
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA
Website	MACK

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

MACK's peers: CLNN, CLSD, CORT, CRMD, DARE, ETON, GANX, INBX, LBPH, PCSA, TBPH, URGN, THRD, LIPO, ELVN

*Chart delayed

Analyzing fundamentals for MACK we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is weak. For more detailed analysis please see MACK Fundamentals page.

Watching at MACK technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on MACK Technicals page.